title: [Bilateral chronic and granulomatous total uveitis following cutaneous leishmaniasis].
authors.forename: S
authors.initials: S
authors.lastname: Bouomrani
authors.forename: A
authors.initials: A
authors.lastname: Farah
authors.forename: N
authors.initials: N
authors.lastname: Ayadi
authors.forename: M
authors.initials: M
authors.lastname: Béji
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D005260:Female; D006099:Granuloma / Q000209:etiology* / Q000469:parasitology; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000150:complications* / Q000188:drug therapy; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D008775:Methylprednisolone / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use; D015864:Panuveitis / Q000188:drug therapy / Q000209:etiology* / Q000469:parasitology; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D011241:Prednisone; D008775:Methylprednisolone